Studies on Coagulation and Fibrinolysis in Pregnancy

Abstract. Studies on coagulation and fibrinolysis were performed on 40 healthy women who underwent an uncomplicated pregnancy. From each subject, samples were taken 6‐10 times during pregnancy, and all the changes were related to the subjects' own 6‐week postpartum values. Increased concentration of coagulation factors II‐VII‐X was revealed by Normotest. The incidence of cold activation of factor VII increased from 14% in non‐pregnant women in these series to 94% in pregnant women near term. A marked increase in the proteolytic capacity was probably an effect of increased plasminogen concentration and decreased antifibrinolytic activity. The latter did not, however, parallel the immunological determination of the antiplasmins. The concentrations of antithrombin III and CI inactivator of complement both decreased during pregnancy. It is concluded that the overall effect of these changes is probably in favour of coagulation.

[1]  K. Laake,et al.  Components of the kallikrein-kinin system and the spontaneous cold activation of factor VII in human plasma. , 2009, Acta pharmacologica et toxicologica.

[2]  H. Gjønnaess.  Cold promoted activation of Factor VII. V. Relation to the fibrinolytic system. , 1973, Thrombosis et diathesis haemorrhagica.

[3]  H. Gjønnaess.  Cold promoted activation of Factor VII. Occurrence and relation to sex hormones and antifertility compounds. , 1973, Gynecologic investigation.

[4]  H. Gjønnaess.  Cold promoted activation of factor VII. I. Evidence for the existence of an activator. , 1972, Thrombosis et diathesis haemorrhagica.

[5]  H. Gjønnaess.  Cold promoted activation of factor VII. II. Identification of the activator. , 1972, Thrombosis et diathesis haemorrhagica.

[6]  B. Åstedt.  On Fibrinolysis: A. In Pregnancy, Labour, Puerperium and During Treatment with Sex Hormones B. In Human Ontogenesis and in Human Organ Culture , 1972, Acta obstetricia et gynecologica Scandinavica. Supplement.

[7]  M. Fagerhol,et al.  2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase. , 1972, Scandinavian journal of clinical and laboratory investigation.

[8]  A. Böyum,et al.  Electronic platelet counting. , 1971, Scandinavian journal of clinical and laboratory investigation.

[9]  N. Moe.  [Thrombosis in normal pregnancy]. , 1971, Tidsskrift for Den Norske Laegeforening.

[10]  U. Hedner,et al.  Studies on Fibrinolytic Inhibitors During Pregnancy , 1971, Acta obstetricia et gynecologica Scandinavica.

[11]  S. Wessler.  The role of hypercoagulability in venous and arterial thrombosis. , 1971, Cardiovascular clinics.

[12]  P. Harpel.  HUMAN PLASMA ALPHA 2-MACROGLOBULIN , 1970, The Journal of experimental medicine.

[13]  P. Harpel.  C[unk] inactivator inhibition by plasmin , 1970 .

[14]  P. Harpel.  C1 inactivator inhibition by plasmin. , 1970, The Journal of clinical investigation.

[15]  J. Ygge.  Changes in blood coagulation and fibrinolysis during the puerperium. , 1969, American journal of obstetrics and gynecology.

[16]  C. Jacobsen.  The use of N-ethyl-urethan in plasma plasminogen assay. , 1968, Scandinavian journal of clinical and laboratory investigation.

[17]  C. Jacobsen.  Proteolytic capacity in human plasma. I. Measurement of proteolytic activity in the presence of natural inhibitors and study of the inter-individual variations. , 1968, Scandinavian journal of clinical and laboratory investigation.

[18]  I. Nilsson,et al.  Coagulation And Fibrinolytic Studies During Pregnancy 1 , 1967 .

[19]  B. Bjerre,et al.  α1‐Antitrypsin and α2‐Macroglobulin Concentration in Serum During Pregnancy , 1967, Acta Obstetricia et Gynecologica Scandinavica.

[20]  H. Stamm.  Thromboembolische Komplikationen in der Schwangerschaft , 1967 .

[21]  S. Kullander,et al.  Coagulation and fibrinolytic studies during pregnancy. , 1967, Acta obstetricia et gynecologica Scandinavica.

[22]  V. Donaldson.  Serum inhibitor of C'1-esterase in health and disease. , 1966, The Journal of laboratory and clinical medicine.

[23]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.

[24]  O. Egeberg.  Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.

[25]  H. Godal,et al.  In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA). , 1965, Scandinavian journal of clinical and laboratory investigation.

[26]  S. Stone,et al.  BLOOD CLOTTING FACTORS IN PREGNANCY: FACTOR 8 CONCENTRATIONS IN NORMAL AND AHF-DEFICIENT WOMEN. , 1964, Obstetrics and gynecology.

[27]  S. Blix.  The proactivator of the fibrinolytic system in human plasma. The quantitative determination and its clinical application. , 2009, Acta medica Scandinavica.

[28]  P. Owren.  Thrombotest. A new method for controlling anticoagulant therapy. , 1959, Lancet.